COVID-19 In Vitro Diagnostic Devices and Test Methods Database
The objective of the JRC COVID-19 In Vitro Diagnostic Devices and Test Methods Database is to collect in a single place all publicly available information on performance of CE-marked in vitro diagnostic medical devices (IVDs) as well as laboratory-developed devices and related test methods for COVID-19. The database is manually curated and periodically updated.
Browse the data
COVID-19 in vitro diagnostic medical devices
- All Immuno assay devices
- All Nucleic acid devices
- All CE Marking devices
- All Rapid antigen tests with CE Marking
- All Rapid antigen tests in HSC common list
This section of the database is based on publicly available information from manufacturers.
The conformity of the devices with applicable EU law has NOT been in any way assessed by the European Commission or Member State national authorities for the purposes of inclusion in the database. There is no central approval system for in vitro diagnostic medical devices in the EU and the database does NOT represent a list of authorised or approved devices in the European Union.
For rapid antigen tests, as part of the EU Health Security Committee (HSC), the Member States have agreed on a common list of these tests considered appropriate for use in the context of COVID-19 diagnosis, as well as a selection of these whose results should be mutually recognised.
Scientific literature on COVID-19 test methods and devices
SARS-CoV-2 NAAT target regions
EUnetHTA publications repository
Explore the data
Contribute
Additional information for manufacturers